Fate Therapeutics
FATE
#8379
Rank
HK$2.20 B
Marketcap
HK$18.90
Share price
-4.37%
Change (1 day)
88.09%
Change (1 year)

Fate Therapeutics (FATE) - Total debt

Total debt on the balance sheet as of March 2026 : HK$0.60 Billion

According to Fate Therapeutics 's latest financial reports the company's total debt is HK$0.60 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Fate Therapeutics - Total debt on balance sheet (from 2012 to 2026)

Total debt by year

Year Total debt Change
2025-12-31HK$0.60 B-8.5%
2024-12-31HK$0.66 B-18.14%
2023-12-31HK$0.80 B-5.35%
2022-12-31HK$0.85 B-4.58%
2021-12-31HK$0.89 B18.7%
2020-12-31HK$0.75 B259.67%
2019-12-31HK$0.20 B79.92%
2018-12-31HK$0.11 B0.74%
2017-12-31HK$0.11 B39.59%
2016-12-31HK$82.88 M-41.37%
2015-12-31HK$0.14 B-7.06%
2014-12-31HK$0.15 B1032.41%
2013-12-31HK$13.43 M-52.83%
2012-12-31HK$28.47 M-24.25%
2011-12-31HK$37.58 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Becton Dickinson
BDX
HK$135.50 B 22,403.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$8.12 B 1,250.09%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
HK$3.09 B 414.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$3.18 B 429.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
HK$0.38 B-35.86%๐Ÿ‡บ๐Ÿ‡ธ USA